Priming the Pipeline
Major drug firms have marshaled new technologies and business practices in discovery and development--have they jump-started the machine?
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
February 16, 2004 Cover
Volume 82, Issue 7
Major drug firms have marshaled new technologies and business practices in discovery and development--have they jump-started the machine?
Credit:
Major drug firms have marshaled new technologies and business practices in discovery and development--have they jump-started the machine?
Evidence continues to accumulate that mold can cause illness, but the degree of hazard is unclear
Technology for nanoparticle zinc oxide gives Moroccan company a noncommodity niche
Thin tubes between cells transport organelles but block small molecules
Kilogram-scale production and biocatalysis are sunny spots on the custom landscape
Dampness brings mold in; volatile compounds, ergosterol, and a glucan reveal its presence